Thymus regeneration promotes naïve T-cell recovery in iMycTg aging-E mice and a partial decrease in Treg frequencies. by Abigail Morales-Sánchez (21799582)

Simulated response to Ach at activated NALCN channels and decreased phosphodiesterase (PDE) activity in low glucose. by Leonid E. Fridlyand (2636968)

“…<p>(A) PM potentials (V_p); (B) [Ca²⁺]_c and [Ca²⁺]_ER; (C) Cytoplasmic cAMP and IP₃ concentrations. …”

Immunofluorescence analyses of peroxisomes labelled with catalase (CAT), and PEX5p in the molars of wildtype, <i>Pex11b</i>-heterozygous and -knockout mice. by Claudia Colasante (101665)

The mutation D2267N within the G3 domain decreases the complement activation capacity. by Camilla Melin Fürst (402462)

CLE mutation decreases H3K27me3 levels on the viral IR. by Jacqueline Williams (3493745)

Ba₂NaClP₂O₇: Unprecedented Phase Matchability Induced by Symmetry Breaking and Its Unique Fresnoite-Type Structure by Jie Chen (5892)

“…Herein, we report a unique Ba₂NaClP₂O₇ representing the first phase-matchable example of the fresnoite family, which exhibits excellent NLO properties, including short absorption edge (<176 nm, ca. 7.0 eV), strong second-harmonic generations at the incident lasers of 850–1110 nm (obv. 0.9–1.3 × KDP; cal. …”

Activity of WT and GAD65-KO and blood EtOH concentration. by Wataru Matsunaga (3452621)

miR-214 decreased the number of viable cells and induced apoptosis in HSA cell lines. by Kazuki Heishima (791938)

“…<p>(A) Cell viability was assessed by performing the MTT assay. miR-214-transfection decreased the number of viable cells in HSA cell lines and that of control EC. …”

BRET² measurement of Gα_qβ₁γ₂ complex activation in HEK293 living cells expressing equal amounts of the WT of human TP receptor or its E1... by Valérie Capra (396007)

“…Agonist-induced coupling of TP receptor and Gq protein distances Gα_q-Rluc8 and GFP¹⁰-Gγ₂ giving rise to a decrease in the BRET signal. B. Protein expression levels of the constructs used for BRET experiments were set to be constant and able to assure the same level of basal BRET ratio in the presence of WT and E129V mutant of the human TP receptors. …”

BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK^mutants. by Richard Junior Zapata Dongo (17912565)

TLR4 receptor inhibition decreased ranibizumab and aflibercept mediated CCL2, CCL5, and CX3CL1 mRNA and protein levels in HCAECs. by Clare Arnott (2557705)

S1 Data - by Richard Junior Zapata Dongo (17912565)

“…In addition, our analysis using bioinformatics indicated that ABT-199 not only targets BCL2 but also binds to the active site of all ALK mutants, it was contrasted by <i>in vitro</i> ALK kinase activity inhibition by ABT-199 (5.5 μM). This interaction was further supported by a significant decrease of ALK phosphorylation in single and combination treatment with 300nM ABT-199. …”

(goes with Fig 5). by Patrick A. Carroll (11586792)

Inhibition of Ric-8A or Gα_i activity decreases the production of PtdIns(3)P in a Vps34 activity dependent manner. by Cedric Boularan (269965)

miR-181b regulates vascular stiffness age dependently in part by regulating TGF-β signaling - Fig 4 by Daijiro Hori (3850915)

Fig 5 - by Xiajun Zhang (3161865)

Subjects:

Blue-light perception defect at decreasing levels of <i>AtPP7</i> expression is compensated under a triggering threshold. by Thierry Genoud (50956)

Change of SMAD4 after TGFβ inhibitor /activator treatment. by Jingping Ge (636557)

“…Protein levels were measured by Western blot analysis. A) Decrease of total p-SMAD2 after SB431542 treatment in all iPSCs, and increase of p-SMAD2 in both DBA iPSCs after the TGFβ1 treatment. …”

UV dose responses by sequential UV-A followed by UV-C exposure for (A) MS2 and (B) E. coli K-12 in PBS and NOM. by Daniel Ma (12698752)

PhoU is not substituted by artificial upregulation of σ^S<i>via arcB</i> or <i>rssB</i> deletions, but is suppressed by deletion of <i>arcA</i>. by Janet L. Gibson (736950)